TCL Archive Translucent Walls, Modern Classics Create “Corporate Feel” In Office Suite Occupied By Wife of MD Anderson President DePinho May 24, 2013
TCL Archive Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study June 21, 2002
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
